This inventor holds 1 USPTO granted patent and 3 published patent applications and 2 EPO patents. Top assignees: Assistance Publique-Hopitaux De Paris, National Institute of Health and Medical Research, Université Paris Descartes. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:




Years Active: 2020
Title: Emmanuel Weiss: Innovator in Medical Prediction Methods
Introduction
Emmanuel Weiss is a notable inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in predicting patient outcomes for those suffering from decompensated alcoholic cirrhosis. His innovative approach has the potential to improve patient care and treatment strategies.
Latest Patents
Emmanuel Weiss holds a patent for "Methods for predicting the survival time of patients with decompensated alcoholic cirrhosis." This invention involves a method that predicts a patient's survival time by determining the expression level of OAS2 or MX2 in a sample of peripheral blood mononuclear cells. The method compares the determined level with a predetermined reference value to conclude the patient's survival prognosis.
Career Highlights
Throughout his career, Emmanuel Weiss has worked with esteemed institutions such as the National Institute of Health and Medical Research and Université Paris Diderot-Paris 7. His work has been instrumental in advancing medical research and improving patient outcomes.
Collaborations
Emmanuel Weiss has collaborated with notable colleagues, including Pierre-Emmanuel Rautou and Richard Moreau. These partnerships have contributed to the development of innovative medical solutions.
Conclusion
Emmanuel Weiss is a distinguished inventor whose work in predicting survival times for patients with decompensated alcoholic cirrhosis showcases his commitment to advancing medical science. His contributions are vital for improving patient care and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile